Heat Stress and Physiological Strain of Permeable vs. Impermeable CB Protective Garment

Sponsor
Medical Corps, Israel Defense Force (Other)
Overall Status
Unknown status
CT.gov ID
NCT01221012
Collaborator
(none)
12
1
48
0.3

Study Details

Study Description

Brief Summary

Current protective clothing of any kind, especially the nuclear-biological-chemical (NBC) protective garments, amplify thermal stress because of the inherent properties of the clothing material. High insulation coefficient and low water vapor permeability of the protective cloth limit the ability of sweat to readily evaporate, which consequently result with a significant elevation of body temperature and with excessive body fluid loss (because of inefficient sweating) that might result with significant dehydration.

Combat soldiers require to perform intense physical activities under hostile environmental conditions, including in contaminated areas that need the use of protective garments. The ability to fulfill a mission derives from the soldier's professionalism and from his physiological limits. It is well established that wearing protective garments affect tolerance time (TT) and performance.

To operate in contaminated areas suitable protective garments should be worn. The inherent characteristics of the current protective garments limit, however, the effective working periods with such an ensemble, which is further aggravated in hot climate. Thus, in an attempt to increase TT and enhance work effectiveness, improved protective garments, which result with a lessened heat-stress, are under different stages of development.

The relative influence of air permeability properties, garment weight and garment construction on heat stress and physiological strain will be investigated.

The results will be quantified in terms of body temperatures, heart rate, fluid balance, subjective sensation and the maximum wear time (if necessary extrapolated).

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    12 participants
    Observational Model:
    Case-Control
    Study Start Date :
    Dec 1, 2010
    Anticipated Primary Completion Date :
    Dec 1, 2013
    Anticipated Study Completion Date :
    Dec 1, 2014

    Arms and Interventions

    Arm Intervention/Treatment
    men wearing Semipermeable garment

    air permeable garment type BP2

    air permeable garment type BP3

    air permeable garment type MO

    air permeable garment type BP1

    Outcome Measures

    Primary Outcome Measures

    1. The physiological burden of different CB Protective Garments [1 year]

      The physiological burden of different CB Protective Garments will be mesured by a heat tolerance test (HTT). The subjects will undergo an HTT wearing different CB Protective Garments and the results which indicate physiological burden will be compared between the different garments.

    Secondary Outcome Measures

    1. Rectal temperature [1 year]

      The rectal temperature will be mesured by rectal thermistore.

    2. Skin temperature [1 year]

      The skin temperature will be mesured by skin thermistores conected to 3 different sites (chest, leg and arm).

    3. Heart rate [1 year]

      Heart rate will be mesured by a polar watch.

    4. Sweat rate [1 year]

      The sweat rate will be calculated in each HTT from the subject's weight before and after the test and his water balance.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    20 Years to 30 Years
    Sexes Eligible for Study:
    Male
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Twelve young (20-30 yr) male subjects will voluntarily participate in this study. The potential participants will be informed of the study's nature, purpose and medical risks. Their inclusion in the study requires the medical clearance by the study's physician (CRF) and after having filled out and sign an informed consent form
    Exclusion Criteria:
    • heart conditions, blood pressure higher than 140/90 mmHg, known diabetes or any skin illness or lesions. Also be excluded are potential participants who were ill during the 2 weeks prior to the study

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Sheba medical center Ramat Gan Israel

    Sponsors and Collaborators

    • Medical Corps, Israel Defense Force

    Investigators

    • Principal Investigator: Amit Druyan, M.D, Medical Corps, Israel Defense Force

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    amit druyan, Principal Investigator, Medical Corps, Israel Defense Force
    ClinicalTrials.gov Identifier:
    NCT01221012
    Other Study ID Numbers:
    • 883-2009-CLIT
    First Posted:
    Oct 14, 2010
    Last Update Posted:
    Mar 29, 2012
    Last Verified:
    Mar 1, 2012

    Study Results

    No Results Posted as of Mar 29, 2012